Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 15/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.37 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.37 |
| ▸ | DLK1 | P80370 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625703 | 0.90 | MAP3K12 (0.44) | MAP3K12PIK3CAF2RL3DLK1 | |
| SCHEMBL626242 | 0.86 | PIK3CA (0.52) | MAP3K12PIK3CAUSP2ALDH1A1CYP3A4 | |
| SCHEMBL626620 | 0.84 | MAP3K12 (0.52) | MAP3K12PIK3CADLK1 | |
| SCHEMBL625459 | 0.84 | MAP3K12 (0.41) | MAP3K12PIK3CAF2RL3DLK1 | |
| SCHEMBL627020 | 0.84 | RET (0.40) | MAP3K12PIK3CAF2RL3PIK3R1 | |
| SCHEMBL626263 | 0.82 | TNF (0.42) | MAP3K12PIK3CA | |
| SCHEMBL626161 | 0.81 | MAP3K12 (0.46) | MAP3K12PIK3CA | |
| SCHEMBL626462 | 0.81 | PKM (0.40) | MAP3K12PIK3CAF2RL3 | |
| SCHEMBL624439 | 0.80 | MAP3K12 (0.41) | MAP3K12PIK3CADLK1 | |
| SCHEMBL624968 | 0.79 | MAP3K12 (0.43) | MAP3K12PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |